Item 2.02.                   Results of Operations and Financial Condition.

On January 31, 2023, Edwards Lifesciences Corporation, a Delaware corporation ("Edwards"), issued a press release setting forth Edwards' financial results for the fourth quarter of 2022. A copy of the press release is furnished as Exhibit 99.1, and is incorporated herein by reference.



The information furnished under this Item 2.02, including Exhibit 99.1, shall
not be deemed to be "filed" for purposes of the Securities Exchange Act of 1934,
as amended.


Item 9.01.                   Financial Statements and Exhibits.


      (d)      Exhibits

               Press release, dated January 31, 2023, reporting Edwards' financial results for
      99.1     the fourth quarter of 2022.



                                       2

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses